Nobilis Health Corp. Reaffirms NYSE MKT Listing Compliance, Clarifies Recent Form 5 Filings

February 16, 2016

HOUSTON, TX -- (Marketwired) -- 02/16/16 -- In response to inquiries received about its NYSE MKT listing status and recent Form 5 filings, Nobilis Health Corp. (NYSE MKT: HLTH) (TSX: NHC) ("Nobilis" or the "Company") today provided the following clarifications:

NYSE MKT Listing Compliance
Nobilis fully resolved the continued listing deficiency with respect to Sections 134 and 1101 of the NYSE MKT LLC's Company Guide, referenced in the Company's press release of January 7, 2016, by filing its Form 10-Q for the period ended September 30, 2015 with the Securities and Exchange Commission ("SEC") on January 13, 2016.

Form 5
Nobilis recently filed SEC Form 5s on behalf of certain executives of Nobilis pursuant to US securities regulations. Some disclosure media and databases have relayed this information without specifically noting that the reported trades occurred during the Company's May 13, 2015 private placement and had been previously reported on SEDI in Canada.

About Nobilis Health Corp.
Nobilis ( utilizes innovative direct-to-patient marketing focused on a specified set of procedures that are performed at our centers by local physicians. Currently, Nobilis owns four surgical hospitals and four ASCs, partners with an additional thirty-three facilities throughout the country, and markets six independent brands.

Forward-Looking Statements
This press release contain certain forward-looking statements within the meaning of Canadian and United States securities laws, including the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts and may be identified by the use of words such as "may," "believe," "will," "expect," "project," "estimate," "anticipate," "plan" or "continue." These forward-looking statements are based on current plans and expectations and are subject to a number of risks, uncertainties and other factors which could significantly affect current plans and expectations and our future financial condition and results. These factors, which could cause actual results, performance and achievements to differ materially from those anticipated, include, but are not limited to the risk that we may face challenges managing our new Marketing Segment and may not realize anticipated benefits; our ability to successfully maintain effective internal controls over financial reporting; our ability to implement our business strategy, manage the growth in our business, and integrate acquired businesses; the risk of litigation and investigations, and liability claims for damages and other expenses not covered by insurance; the risk that payments from third-party payers, including government healthcare programs, may decrease or not increase as costs increase; adverse developments affecting the medical practices of our physician limited partners; our ability to maintain favorable relations with our physician limited partners; our ability to grow revenues by increasing case and procedure volume while maintaining profitability at the Nobilis Facilities; failure to timely or accurately bill for services; our ability to compete for physician partners, patients and strategic relationships; the risk of changes in patient volume and patient mix; the risk that laws and regulations that regulate payments for medical services made by government healthcare programs could cause our revenues to decrease; the risk that contracts are cancelled or not renewed or that we are not able to enter into additional contracts under terms that are acceptable to us; and the risk of potential decreases in our reimbursement rates. The foregoing are significant factors we think could cause our actual results to differ materially from expected results. However, there could be additional factors besides those listed herein that also could affect us in an adverse manner.

We have not undertaken any obligation to publicly update or revise any forward-looking statements. All of our forward-looking statements speak only as of the date of the document in which they are made or, if a date is specified, as of such date. Subject to an mandatory requirements of applicable law, we disclaim any obligation or undertaking to provide any updates or revisions to any forward-looking statement to reflect any change in our expectations or any changes in events, conditions, circumstances or information on which the forward-looking statement is based. All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the foregoing factors and in our Amendment No. 1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2014, filed on January 13, 2016, as updated by other filings with the Securities and Exchange Commission and on SEDAR.

Contact Information:
Stephen Kilmer
Investor Relations
Tel (US): (888)-545-6374
Tel (Can): (646) 274-3580

Source: Nobilis Health Corp.